Atypical pigmented lesions following extensive PUVA therapy.
We report a 38-year-old woman with psoriasis who developed multiple atypical lentigines following psoralen photochemotherapy (PUVA). The lentigines first appeared 12 years ago, 3 years after she commenced intermittent PUVA treatment. New lesions continued to develop over the subsequent years with further photochemotherapy. Clinically, the lentigines were strikingly atypical, deeply pigmented, dark brown or black, large stellate macules. Histology of a representative lesion was consistent with a PUVA lentigo and no atypical melanocytes were seen. At present, a link between malignant melanoma and PUVA lentigines has not been established. Instead, limited evidence suggests that PUVA lentigines may be more closely linked with the risk of nonmelanoma skin cancer.
Basarab
T
T
St John's Institute of Dermatology, St Thomas' Hospital, London, UK.
Millard
T P
TP
McGregor
J M
JM
Barker
J N
JN
D000328:Adult; D005260:Female; D006801:Humans; D007911:Lentigo / Q000209:etiology* / Q000473:pathology; D011701:PUVA Therapy / Q000009:adverse effects*; D011565:Psoriasis / Q000188:drug therapy